These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23585824)

  • 21. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
    Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
    J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.
    Yan Z; Fan K; Wang Y; Fan Y; Tan Z; Deng G
    Hepat Mon; 2012 Mar; 12(3):196-204. PubMed ID: 22550528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis C infection among intravenous drug users in Shanghai.
    Tao YL; Tang YF; Qiu JP; Cai XF; Shen XT; Wang YX; Zhao XT
    World J Gastroenterol; 2013 Aug; 19(32):5320-5. PubMed ID: 23983436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
    Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
    J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains.
    Niculescu I; Paraschiv S; Paraskevis D; Abagiu A; Batan I; Banica L; Otelea D
    AIDS Res Hum Retroviruses; 2015 May; 31(5):488-95. PubMed ID: 25369079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.
    Samimi-Rad K; Nasiri Toosi M; Masoudi-Nejad A; Najafi A; Rahimnia R; Asgari F; Shabestari AN; Hassanpour G; Alavian SM; Asgari F
    Arch Virol; 2012 Oct; 157(10):1959-65. PubMed ID: 22695769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
    Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
    Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
    Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
    Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
    Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China.
    Zhang Z; Yao Y; Wu W; Feng R; Wu Z; Cun W; Dong S
    PLoS One; 2013; 8(12):e82598. PubMed ID: 24358211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities.
    Oyaro M; Wylie J; Chen CY; Ondondo RO; Kramvis A
    South Afr J HIV Med; 2018; 19(1):737. PubMed ID: 29707384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.
    Kitayaporn D; Vanichseni S; Mastro TD; Raktham S; Vaniyapongs T; Des Jarlais DC; Wasi C; Young NL; Sujarita S; Heyward WL; Esparza J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):289-95. PubMed ID: 9803972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients.
    Salehi Moghadam F; Mohebbi SR; Hosseini SM; Romani S; Mirtalebi H; Azimzadeh P; Damavand B; Naghoosi H; Khanyaghma M; Sanati A; Zali MR
    J Med Virol; 2014 Aug; 86(8):1342-9. PubMed ID: 24838700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.